Exicure (NASDAQ:XCUR – Get Free Report) and NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Insider and Institutional Ownership 42.8% of Exicure shares […]
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
NAARDEN, the Netherlands and MIAMI, May 03, 2024 NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of.
NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin
NewAmsterdam Pharma (NASDAQ:NAMSW – Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 13,300 shares, an increase of 66.3% from the March 31st total of 8,000 shares. Based on an average daily volume of 12,500 shares, the […]